5 Questions with Kurt Elam, Senior Director, Sales & Marketing for LabOwl

Published on :

Kurt Elam joined ACC/Lab Owl in 2017 with 20+ years of specialty biopharmaceutical experience, focused primarily on oncology, infectious disease, and critical care/ICU medicine. He has overseen and managed the successful launch of over 16 new FDA approved products/compounds or new indications, and worked to gain formulary approval in managed care organizations, thereby improving access for patients.

5 Questions with Chad Schneider, PE, MSE, President & Founder of Root3 Labs

Published on :

Mr. Schneider is a mechanical design engineer with over 20 years of engineering experience in the design of complex electromechanical prototypes and products. He earned a BS in mechanical engineering with Honors from the University of Maryland, College Park, and a MSE in mechanical engineering from Johns Hopkins University with a focus on haptics and medical robotics. In 2012, he founded Root3 Labs to focus on practical R&D for the medical device and defense industries.

Emergent Biosolutions Seeks Biomanufacturing Talent for Three Maryland Manufacturing Facilities at Forefront of COVID-19 Battle

Published on :

Maryland’s leading vaccine manufacturer, Emergent Biosolutions (Emergent) is a global biopharmaceutical company that has become a key player in the BioHealth Capital Region’s (BCHR) fight against COVID-19.

5 Questions with Nick Droste, Supervisor, Emergent BioSolutions Postfill Manufacturing Supervisor

Published on :

Andrew Davis is Vice President at Scheer Partners and helps run the scientific real estate practice. Andrew lives in Maryland but assists scientific companies identify, negotiate, and build space in the Biohealth Capital Region, Philadelphia / Greater PA, and Massachusetts.